PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURS
- 1 April 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 319 (8275) , 762-765
- https://doi.org/10.1016/s0140-6736(82)91811-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Ex vivo perfusion of a tumor-containing colon with monoclonal antibodyJournal of Surgical Research, 1981
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981
- Serotherapy of acute lymphoblastic leukemia with monoclonal antibodyBlood, 1981
- In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemiaBlood, 1981
- Specific Antigen in Serum of Patients with Colon CarcinomaScience, 1981
- A Monosialoganglioside Is a Monoclonal Antibody-Defined Antigen of Colon CarcinomaScience, 1981
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinomaEuropean Journal of Immunology, 1979
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences, 1979
- Study of antibodies against human melanoma produced by somatic cell hybrids.Proceedings of the National Academy of Sciences, 1978